Von Eschenbach elaborates on collaboration
This article was originally published in The Gray Sheet
Executive Summary
"We are in a model of healthcare where we are looking at things in fragmented...and segmented opportunities," said FDA Acting Commissioner Andrew von Eschenbach, MD, at a meeting of the Personalized Medicine Coalition in Washington, D.C., March 6. "There will always be separate partitions and individual missions and uniqueness," he said. But we need "to find out how we can partner, integrate and collaborate" to provide the best patient care. Von Eschenbach pointed to a Memorandum of Understanding between FDA, the National Cancer Institute and CMS signed in January as progress on this front. Von Eschenbach could be tapped as the permanent FDA commissioner in the next month and a half...